3/11/2024 | 30039090 | (FOC ITEMS) OTT166 SOLUTION 50MG/MLBATCH 233648 | XXXXXXXXXX | 1 | UNT | 55.34 | FINLAND | BANGALORE AIR |
3/11/2024 | 30039090 | (FOC ITEMS) OTT166 SOLUTION 50MG/MLBATCH cl70014-023-0222 | XXXXXXXXXX | 2 | UNT | 110.68 | FINLAND | BANGALORE AIR |
12/19/2023 | 30039090 | POTASSIUM CLAVULANATE WITH SILICON DIOXIDE (1:1) I.P., E.P. (FOR HUMAN PRODUCTS CONSUMPTION ONLY) 30 | XXXXXXXXXX | 200 | KGS | 22685.25 | South Korea | DELHI ACC |
12/19/2023 | 30039090 | POTASSIUM CLAVULANATE WITH SILICON DIOXIDE (1:1) I.P., E.P. (SAMPLE FOR TESTING PURPOSE ONLY) 30 | XXXXXXXXXX | 1 | KGS | 113.43 | South Korea | DELHI ACC |
12/11/2023 | 30039090 | BATCH R6401522 SUGAMMADEX INJ., USP 200MG/2ML, OF24 UNIT X16CRTN SYRINGES WITH 2.25ML SGM(FOR R&D) TL/NZ/23/000289 30 | XXXXXXXXXX | 384 | NOS | 2547.23 | USA | DELHI ACC |
12/11/2023 | 30039090 | BATCH R6401523 SUGAMMADEX INJ., USP 200MG/2ML, OF24 UNIT X16CRTN SYRINGES WITH 2.25ML SGM(FOR R&D) TL/NZ/23/000289 30 | XXXXXXXXXX | 384 | NOS | 2547.23 | USA | DELHI ACC |
12/11/2023 | 30039090 | BATCH R6401521 SUGAMMADEX INJ,USP 200MG/2ML, OF24 UNIT X 16CRTN SYRINGES WITH 2.25ML SGM(FOR R&D) TL/NZ/23/000289 30 | XXXXXXXXXX | 384 | NOS | 2547.23 | USA | DELHI ACC |
11/25/2023 | 30039090 | POTASSIUM CLAVULANATE WITH SILICON DIOXIDE (1:1) I.P | XXXXXXXXXX | 600 | KGS | 60619.89 | South Korea | SAHAR AIR CARGO ACC |
11/23/2023 | 30039090 | MEDICAMENTS CONSISTING OF 2 OR MORE CONSTITUENTS MIXED TOGETHER,IMP LIC NO.BD-934-19663 DT-27-4-23(PANCREATIN MMS 25000) | XXXXXXXXXX | 1200 | KGS | 991342.11 | GERMANY | SAHAR AIR CARGO ACC |
11/21/2023 | 30039090 | XOLAIR DS E25PP030/A/3 832274 BATCH-BF0051 (REFERANCE STANDARD) | XXXXXXXXXX | 3 | PCS | 2237.22 | FRANCE | SAHAR AIR CARGO ACC |